One of the most significant – and relatively recent – innovations in the treatment of cancer are so-called immuno-oncology (IO) drugs. As today’s article explains, these drugs “enlist a patient’s immune system in the fight, giving it marching orders to tackle cancer cells…Under the right circumstances, the best IO performers can make traditional chemotherapy or surgery far more effective, or potentially even replace them”. For more on the potential of IO drugs to become “miracle” treatments for a range of cancers – and some pharmaceutical companies experiencing early success in the space – CLICK HERE.